Ginkgo Bioworks DNA Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Ginkgo Bioworks’s reported figures.
Based on trailing twelve months.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ginkgo Bioworks's operating margin?
- Ginkgo Bioworks (DNA) reported operating margin of -210.7% in Q1 2026.
- How has Ginkgo Bioworks's operating margin changed year-over-year?
- Ginkgo Bioworks's operating margin decreased by 3.5% year-over-year, from -203.5% to -210.7%.
- What is the long-term trend for Ginkgo Bioworks's operating margin?
- Over 4 years (2021 to 2025), Ginkgo Bioworks's operating margin has grown at a -24.2% compound annual growth rate (CAGR), from -582.6% to -192%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.